Skip to Content

707 SP 7.5 (Univasc 7.5 mg)

Generic Name: moexipril

Pill imprint 707 SP 7.5 has been identified as Univasc 7.5 mg.

Univasc is used in the treatment of diabetic kidney disease; high blood pressure; heart attack; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Univasc 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Univasc 7.5 mg 707 SP 7.5
Univasc 7.5 mg 707 SP 7.5
Univasc 7.5 mg 707 SP 7.5 Front
Univasc 7.5 mg 707 SP 7.5 Back
Univasc
Generic Name:
moexipril
Imprint:
707 SP 7.5
Strength:
7.5 mg
Color:
Pink
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Schwarz Pharma
National Drug Code (NDC):
00091-3707
Inactive Ingredients:
lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose (type h)
hypromelloses
polyethylene glycol 6000
titanium dioxide
ferric oxide red

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide